Summary
3M Company (MMM) has officially completed the separation of its health care business, now named Solventum Corporation (SOLV), through a pro rata stock distribution. This significant event, effective April 1, 2024, means 3M stockholders received shares of Solventum as a separate, independent public company listed on the NYSE under the ticker "SOLV". This strategic move is designed to allow both 3M and Solventum to pursue distinct growth strategies and enhance shareholder value by focusing on their respective core competencies. The filing also provides investors with access to important pro forma financial information. These unaudited financial statements offer a view of 3M's financial position and performance as if the separation had occurred at earlier dates, enabling a clearer understanding of the ongoing business's standalone financial profile and the impact of this strategic divestiture.
Key Highlights
- 13M completed the separation of its health care business on April 1, 2024.
- 2The separated health care business now operates as an independent public company named Solventum Corporation (SOLV).
- 3Solventum's common stock began trading on the New York Stock Exchange (NYSE) under the ticker symbol "SOLV".
- 43M stockholders received 80.1% of Solventum's shares through a pro rata distribution.
- 5Shareholders of record on March 18, 2024, received one share of Solventum for every four shares of 3M held.
- 6Cash will be provided for fractional Solventum shares.
- 7Unaudited pro forma financial statements reflecting the separation are attached, providing insight into the standalone financial health of both entities.